Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
Küçük Resim Yok
Tarih
2017
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
GALENOS YAYINCILIK
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Prostate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the taxane group that inhibits depolymerization of tubulin and has an antitumoral activity through stabilization of microtubules. It has also been reported that docetaxel therapy lead to cutaneous and eye side effects besides systemic side effects. Skin and eye toxicities are more common with weekly docetaxel treatment than three-week regimens. We would like to present our case of neutropenia, eye and skin toxicities with docetaxel chemotherapy treatment which is commonly used in metastatic prostate cancer patients.
Açıklama
Anahtar Kelimeler
Prostate cancer, conjunctivitis, docetaxel
Kaynak
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
16
Sayı
4
